You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

anti-GITR

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Malignant Solid Tumor, Metastatic Carcinoma in the Liver, Metastatic Carcinoma in the Lung Trial in Houston (drug,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +4 more
  • Anti-GITR Agonistic Monoclonal Antibody BMS-986156
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 30, 2021

Head Neck Cancer Trial in Portland (INCAGN01876, INCMGA00012, DPV-001)

Recruiting
  • Cancer of the Head and Neck
  • Portland, Oregon
    Portland Providence Medical Center
Sep 1, 2021

Squamous Cell Carcinoma of Head and Neck Trial in Spain, United States (REGN6569, Cemiplimab)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Los Angeles, California
  • +9 more
Jun 20, 2022

Glioblastoma, Glioblastoma Multiforme Trial in Baltimore (Nivolumab, Anti-GITR Monoclonal Antibody MK-4166, IDO1 inhibitor

Terminated
  • Glioblastoma
  • Glioblastoma Multiforme
  • Baltimore, Maryland
    Johns Hopkins University/Sidney Kimmel Cancer Center
Jun 30, 2020

Solid Tumors, Lymphomas Trial in Worldwide (GWN323, PDR001)

Completed
  • Solid Tumors
  • Lymphomas
  • Chicago, Illinois
  • +8 more
Feb 18, 2021

Unresectable Stage III or Stage IV Malignant Melanoma or Other Solid Tumor Malignancies Trial in New York (TRX518)

Completed
  • Unresectable Stage III or Stage IV Malignant Melanoma or Other Solid Tumor Malignancies
  • TRX518
  • New York, New York
    Immunotherapeutics Core / Memorial Sloan Kettering Cancer Center
Aug 12, 2019

Hepatocellular Carcinoma Trial in Seongnam-si, Seoul (regorafenib)

Recruiting
  • Hepatocellular Carcinoma
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
  • +1 more
Sep 24, 2022

Basal Cell Carcinoma of the Head and Neck Trial in Cleveland (Pembrolizumab, Tissue collection)

Recruiting
  • Basal Cell Carcinoma of the Head and Neck
  • Cleveland, Ohio
    Cleveland Clinic, Case Comprehensive Cancer Center
Jul 28, 2022

Recurrent Cancer, Metastatic Cancer, Advanced Malignancies Trial (INCAGN01876, retifanlimab)

Recruiting
  • Recurrent Cancer
  • +3 more
  • INCAGN01876
  • retifanlimab
  • Birmingham, Alabama
  • +17 more
Dec 13, 2022

Lumbar Spinal Stenosis Trial in Salt Lake City (Amniotic Fluid Allograft, Dexamethasone sodium phosphate)

Recruiting
  • Lumbar Spinal Stenosis
  • Amniotic Fluid Allograft
  • Dexamethasone sodium phosphate
  • Salt Lake City, Utah
  • +1 more
Nov 22, 2022

Locally Advanced Malignant Tumor, Metastatic Cancer Trial in San Antonio (OMP-336B11)

Terminated
  • Locally Advanced Malignant Neoplasm
  • Metastatic Cancer
  • San Antonio, Texas
    South Texas Accelerated Research Therapeutics, LLC
Aug 10, 2020

Diagnostic Score for Encephalitis to Assess Risk of Autoimmune

Recruiting
  • Autoimmune Encephalitis
  • Autoimmune Encephalitis Caused by N-Methyl D-Aspartate Receptor Antibody (Disorder)
  • Clinical score of Granillo and al.
  • Lyon, France
    Centre de référence des syndromes neurologiques paranéoplasiques
Jul 12, 2023

Thromboprophylactic Dosage Nadroparin in Critically Ill COVID-19

Completed
  • Critical Illness
  • +2 more
  • blood sampling
  • Arnhem, Netherlands
    Monique de Maat
Jun 28, 2023

Technology Trial in Hong Kong (The anti-wandering system)

Not yet recruiting
  • Technology
  • The anti-wandering system
  • Hong Kong, Hong Kong
    Haven of Hope Residential Service for the Disabled
Mar 28, 2023

NSCLC Trial in Beijing, Tianjin (TQB2450 injection, docetaxel injection matching , AL2846 capsules, TQB2450 matching , docetaxel

Recruiting
  • Non-small Cell Lung Cancer
  • TQB2450 injection, docetaxel injection matching placebo, AL2846 capsules
  • TQB2450 matching placebo, docetaxel injection, AL2846 matching placebo
  • Beijing, Beijing, China
  • +2 more
Jun 19, 2023

Seasonal Allergic Rhinitis Trial in China (LP-003 dose 1, LP-003 dose 2, Placebo)

Recruiting
  • Seasonal Allergic Rhinitis
  • LP-003 dose 1
  • +2 more
  • Beijing, Beijing, China
  • +16 more
Sep 18, 2023

Celiac Disease Trial in Spain

Recruiting
  • Celiac Disease
    • Terrassa, Barcelona, Spain
    • +5 more
    Aug 10, 2023

    Thyroid Diseases, Hypothyroidism, Hashimoto Disease Trial in Tehran (curcumin, Anti-inflammatory diet)

    Not yet recruiting
    • Thyroid Diseases
    • +2 more
    • curcumin
    • Anti-inflammatory diet
    • Tehran, National Nutrition And Food Technology Research Institute, Iran, Islamic Republic of
      Golbon Sohrab
    Jul 27, 2023

    Post-endodontic Pain Trial in Cairo (Cryotherapy, Diclofenac sodium, Dexamethasone sodium phosphate)

    Recruiting
    • Post-endodontic Pain
    • Cryotherapy
    • +2 more
    • Cairo, Egypt
      Ain Shams University
    Oct 13, 2023

    T- and B-Cell Subpopulations in Membranous Nephropathy

    Recruiting
    • Membranous Nephropathy
    • +2 more
      • Istanbul, Turkey
        Istanbul University
      May 31, 2023

      Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Merkel Cell Carcinoma AJCC v8, Merkel Cell

      Not yet recruiting
      • Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8
      • +2 more
      • Biopsy
      • +6 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Sep 28, 2023

      Refractory Cancer, Recurrent Cancer, Solid Tumor, Adult Trial in Germany (IMA402 (Phase Ia), IMA402 (Phase Ib), IMA402 (Phase

      Not yet recruiting
      • Refractory Cancer
      • +3 more
      • IMA402 (Phase Ia)
      • +2 more
      • Heidelberg, Baden-Wuerttemberg, Germany
      • +12 more
      Jul 14, 2023

      HER2-positive Gastric Cancer, Immunotherapy Trial in Shanghai (Disitamab Vedotin combined with fruquintinib and Tislelizumab)

      Recruiting
      • HER2-positive Gastric Cancer
      • Immunotherapy
      • Disitamab Vedotin combined with fruquintinib and Tislelizumab
      • Shanghai, Shanghai, China
        Fudan University Shanghai Cancer Center
      Aug 8, 2023

      Locally Advanced Rectal Cancer Trial in Guangzhou (AK104, Capecitabine, Neoadjuvant Radiotherapy)

      Not yet recruiting
      • Locally Advanced Rectal Cancer
      • Guangzhou, Guangdong, China
        Sun Yat-sen University Cancer Center
      Aug 5, 2023

      Wrinkle, Spot Pigmented, Lines Skin Trial in Clearwater (Nutraceutical Topical)

      Recruiting
      • Wrinkle
      • +2 more
      • Nutraceutical Topical
      • Clearwater, Florida
        Laser Scalp and Hair Center
      Feb 9, 2023